Kanabo

About

Funding history · 5 rounds · $12.2M total

Headcount over time

Q&A

When did Kanabo go public and on which exchange?

Kanabo went public on the London Stock Exchange (LSE) in February 2021, with an IPO that raised $8,200,000 at a valuation of $30,000,000.

What is Kanabo's primary focus?

Kanabo Research is a medical cannabis research and development company that provides solutions for the medical cannabis industry, focusing on drug-delivery platforms for medical cannabis.

What is the employee count for Kanabo?

Kanabo has an employee count in the 11-50 range.

What was Kanabo's most recent funding round?

Kanabo completed a Public Offering in February 2022, raising $3,100,000.

What was Kanabo's total funding raised to date?

Kanabo has raised a total of $14,970,000 across all funding rounds.

Has Kanabo formed any recent partnerships for market expansion?

In October 2021, Kanabo announced a partnership with Medocann Group to exclusively develop and distribute unique cannabis strains and products for the UK and German markets.

What was a significant acquisition made by Kanabo in 2022?

In February 2022, Kanabo acquired a national GP online service to improve the 'last mile' for patients, according to Business Wire.

What is Kanabo's core product offering?

Kanabo develops formulations of medical cannabis extracts for vaporization that work with its medically certified VapePod vaporizer platform. This drug-device combination is designed to deliver patent-pending formulations to treat specific ailments.

Team · 2

Avihu Tamir

Founder · Founder & CEO

David Sack

Founder · Co-Founder

Sectors & technology

Highlights

Tags